Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Update on the therapy for myelodysplastic syndrome Kasner MT; Luger SMAm J Hematol 2009[Mar]; 84 (3): 177-86The myelodysplastic syndromes (MDS) are a diverse group of clonal hematopoietic stem cell disorders characterized by cytopenias. Patients have a risk of developing acute leukemia though most succumb to complications of low blood counts. Over the past decade many novel treatments have been developed and investigation of new agents is ongoing. In this article, we discuss the classification and prognostic systems that are used in MDS, the agents available for treatment of MDS as well as review supportive and palliative care options for patients who are not candidates for, or opt against, newer treatment strategies.|*Drug Design[MESH]|Aged[MESH]|Antimetabolites, Antineoplastic/*therapeutic use[MESH]|Clinical Trials as Topic[MESH]|Hematopoietic Stem Cell Transplantation[MESH]|Humans[MESH]|Middle Aged[MESH]|Myelodysplastic Syndromes/classification/*drug therapy/therapy[MESH]|Risk Factors[MESH] |